Form 4 for WGS GeneDx Holdings Corp.
Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-01 · accession 0001944119-25-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | 2025-12-01 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | +717 | 4,570 | +19% | $0 |
| D | 2025-12-03 | 2025-12-01 | WGS | Feeley Kevin | CFO | S - Sale+OE | $162.54 | -377 | 4,193 | -8% | -$61.3K |
| D | 2025-12-03 | 2025-12-01 | WGS | Feeley Kevin | CFO | M - OptEx | $0.00 | -717 | 2,152 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-01 | M | A | 717 | $0.00 | 4,570 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) The reported total includes 96 shares of the Issuer's Class A Common Stock acquired by the reporting person in one or more transactions with the Issuer pursuant to its Employee Stock Purchase Plan, which transactions are exempt pursuant to Rules 16a3(f)(1)(i)(B) and 16b3(c). |
| 2 | Common | Class A Common Stock | 2025-12-01 | S | D | 377 | $162.54 | 4,193 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.3501 to $162.5400, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. (F5) Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 4,193 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 123,163 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms. |
| 3 | Derivative | Restricted Stock Unit | 2025-12-01 | M | D | 717 | $0.00 | 2,152 | D | — · — to — | 717 Class A Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F6) 6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date. |